A review of 11 systematic reviews found limited evidence supporting THC/CBD spray for neuropathic pain and inadequate evidence for cannabinoids treating cancer pain, rheumatic pain, or anorexia.
Read this if you use or are considering cannabis for chronic pain and want to know what the best available evidence actually shows.
750 publications screened; only limited evidence for neuropathic pain, inadequate for cancer and rheumatic pain
What the researchers found
This systematic review of systematic reviews examined the highest-quality evidence available on cannabinoids for pain management and palliative medicine.
Of 750 publications identified, 11 systematic reviews met inclusion criteria. Three were high methodological quality and eight were moderate. The strongest finding was limited evidence supporting THC/CBD spray for neuropathic pain.
For cancer pain, rheumatic pain, gastrointestinal pain, and anorexia in cancer or AIDS, the evidence for any cannabinoid (dronabinol, nabilone, medical cannabis, or THC/CBD spray) was inadequate.
The reviewers highlighted a significant gap between public perception and scientific evidence: the public views cannabis-based medicines as effective and safe for pain, but the systematic evidence does not support this perception. Treatment with cannabis-based medicines was associated with central nervous system and psychiatric side effects.
Why it matters
This is one of the most rigorous assessments of cannabinoids for pain, reviewing reviews rather than individual studies. The clear gap it identifies between public perception and scientific evidence has direct implications for clinical practice and patient expectations.
The numbers in context
750 publications identified; 11 systematic reviews met inclusion criteria (3 high quality, 8 moderate quality). 2 long-term observational studies with medical cannabis and 1 with THC/CBD spray were also analyzed.
How the study worked
Systematic review of systematic reviews of RCTs and prospective observational studies, searching the Cochrane Database, Database of Abstracts of Reviews of Effects, and Medline from January 2009 to January 2017. Methodological quality was assessed using the AMSTAR instrument.
What this study cannot tell us
The search period ended January 2017 and newer evidence may have emerged. The review focused on systematic reviews, meaning individual high-quality studies not yet included in a systematic review would be missed. The included reviews varied in their definitions of pain conditions and cannabinoid formulations.
How to read the evidence
Systematic review of systematic reviews using validated quality assessment (AMSTAR), representing the highest tier of evidence synthesis.
When this study was published
Published in 2017, covering systematic reviews from January 2009 to January 2017.
The bigger picture
This umbrella review illustrates a recurring pattern in cannabinoid research: promising preclinical results and patient reports that do not consistently translate to rigorous clinical evidence. It suggests the field needs larger, better-designed RCTs before cannabinoids can be confidently recommended for pain conditions.
Questions still open
- Could specific cannabinoid formulations or delivery methods show stronger evidence in more targeted trials? Does the limited evidence for neuropathic pain represent a genuinely different mechanism than cancer or rheumatic pain? Would longer-term studies change the evidence picture?
Common questions
Does cannabis work for chronic pain?
Is public perception of cannabis for pain accurate?
Read the original research
Cannabinoids in Pain Management and Palliative Medicine.
Deutsches Arzteblatt international, 114(38), 627-634
Citation
Häuser, Winfried; Fitzcharles, Mary-Ann; Radbruch, Lukas; Petzke, Frank. (2017). Cannabinoids in Pain Management and Palliative Medicine.. Deutsches Arzteblatt international, 114(38), 627-634. https://doi.org/10.3238/arztebl.2017.0627
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk